Современное представление о факторах риска развития колоректального рака

Автор: Мулендеев С.В., Соловьв И.А., Шостка К.Г., Арутюнян К.В., Сахаров А.А., Роман Л.Д.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Рубрика: Обзоры литературы

Статья в выпуске: 3 т.12, 2017 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140188710

IDR: 140188710

Список литературы Современное представление о факторах риска развития колоректального рака

  • Злокачественные новообразования в России в 2014 году (заболеваемость и смертность)/Под ред. А.Д.Каприна, В.В.Старинского, Г.В.Петровой. -М.: МНИОИ им.П.А.Герцена -филиал ФГБУ "НМИРЦ" Минздрава России, 2016. -250 с.
  • Старостина М.А. Биоценоз кишечника у больных колоректальным раком/М.А.Старостина, З.А.Афанасьева, М.С.Губаева и др.//Практич. медицина. -2012. -№ 61. -С. 97-99.
  • Циммерман Я.С. Колоректальный рак: современное состояние проблемы/Я.С.Циммерман//Рос. журн. гастроэнтерол. гепатол. колопроктологии. -2012. -Т. 22, № 4. -С. 5-16.
  • Aloua M.T. Diet influence on the gut microbiota and dysbiosis related to nutritional disorders/M.T.Aloua, J.-C.Lagiera, D.Raoult//Nutrients. -2015. -Vol. 7, N 1. -P. 17-44.
  • Antonic V. Significance of infectious agents in colorectal cancer development/V.Antonic, A.Stojadinovic, K. E.Kester//J. Cancer. -2013. -Vol. 4, N 3. -P. 227-240.
  • Armelao F. Familial colorectal cancer: A review/F.Armelao, G. de Pretis//World J. Gastroenterol. -2014. -Vol. 20, N 28. -P. 9292-9298.
  • Arnold M. Global patterns and trends in colorectal cancer incidence and mortality/M.Arnold, M.S.Sierra, M.Laversanne et al.//Gut. -2016. -http:// href='contents.asp?titleid=16607' title='Gut'>Gut.bmj.com/cont-ent/early/2016/01/05/Gutjnl-2015-310912.
  • Bernabe-Dones R.D. High prevalence of human papillomavirus in colorectal cancer in hispanics: A case-control study/R.D.Bernabe-Dones, M.Gonzalez-Pons, A.Villar-Prados//Gastroenterol. Res. Pract. -2016. -Vol. 2016. -Art. ID 7896716. -8 p.
  • Boleij A. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis/A.Boleij, M.M. van Gelder, D.W.Swinkles et al.//Clin. Infect. Dis. -2011. -Vol. 53, N 9. -P. 870-878.
  • Boleij A. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients/A.Boleij, E.M.Hechenbleikner, A.C.Goodwin et al.//Clin. Infect. Dis. -2015. -Vol. 60, N 2. -P. 208-215.
  • Bonnet M. Colonization of the human gut by E. coli and colorectal cancer risk/M.Bonnet, E.Buc, P.Sauvanet et al.//Clin. Cancer Res. -2014. -Vol. 20, N 4. -P. 859-867.
  • Boulangé C.L. Impact of the gut microbiota on inflammation, obesity, and metabolic disease/C.L.Boulangé, A.L.Neves, J.Chilloux et al.//Genome Med. -2016. -Vol. 8, N 1. -Art. 42.
  • Butt J. Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence/J.Butt, B.Romero-Hernândez, B.Pérez-Gómez et al.//Int. J. Cancer. -2016. -Vol. 138, N 7. -P. 1670-1679.
  • Chen H. Viral infections and colorectal cancer: A systematic review of epidemiological studies/H.Chen, X.-Z.Chen, T.Waterboer et al.//Int. J. Cancer. -2015. -Vol. 137, N 1. -P. 12-24.
  • Chen H.-P. Identification of human cytomegalovirus in tumour tissues of colorectal cancer and its association with the outcome of non-elderly patients/H.-P.Chen, J.-K.Jiang, C.-Y.Chen et al.//J. Gen. Virol. -2016. -Vol. 97. -P. 2411-2420.
  • Clarke G. Minireview: Gut microbiota: the neglected endocrine organ/G.Clarke, R.M.Stilling, P.J.Kennedy et al.//Mol. Endocrinol. -2014. -Vol. 28, N 8. -P. 1221-1238.
  • Clemente J.C. The impact of the gut microbiota on human health: an integrative view/J.C.Clemente, L.K.Ursell, L.W.Parfrey, R.Knight//Cell. -2012. -Vol. 148, N 6. -P. 1258-1270.
  • Coelho T.R. JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?/T.R.Coelho, L.Almeida, P.A.Lazo//Virol. J. -2010. -Vol. 18, N 7. -Art. 42.
  • Conlon M.A. The impact of diet and lifestyle on gut microbiota and human health/M.A.Conlon, A.R.Bird//Nutrients. -2015. -Vol. 7, N 1. -P. 17-44.
  • Delbue S. Review on the role of the human Polyomavirus JC in the development of tumors/S.Delbue, M.Comar, P.Ferrante//Infect. Agents Cancer. -2017. -Vol. 12, N 10. -https://infectagentscancer.biomedcentral.com/articles/10.1186/s13027-017-0122-0.
  • Dimberg J. Detection of cytomegalovirus DNA in colorectal tissue from Swedish and Vietnamese patients with colorectal cancer/J.Dimberg, T.T.Hong, M.Skarstedt et al.//Anticancer Res. -2013 -Vol. 33, N 11. -P. 4947-4450.
  • Flanagan L. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome/L.Flanagan, J.Schmid, M.Ebert et al.//Eur. J. Clin. Microbiol. Infect. Dis. -2014. -Vol. 33, N 8. -P. 1381-1390.
  • Francino M.P. Antibiotics and the human gut microbiome: Dysbioses and accumulation of resistances/M.P.Francino//Front Microbiol. -2015. -Vol. 6. -Art. 1543. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709861/.
  • Gagnière J. Gut microbiota imbalance and colorectal cancer/J.Gagnière, J.Raisch, J.Veziant et al.//World J. Gastroenterol. -2016. -Vol. 22, N 2. -P. 501-518.
  • Galdy S. Streptococcus bovis and colorectal cancer/S.Galdy//Infection and cancer: Bi-Directorial Interactions. -Springer International Publishing, 2015. -Part II. -P. 231-241.
  • Ghittoni R. Role of human papillomaviruses in carcinogenesis/R.Ghittoni, R.Accardi, S.Chiocca, M.Tommasino//Ecancermedicalscience. -2015. -Vol. 9. -Art. 526.
  • Harlid S. The metabolic syndrome, inflammation, and colorectal cancer risk: An evaluation of large panels of plasma protein markers using repeated, prediagnostic samples/S.Harlid, R.Myte, B.Van Guelpen//Med. Inflam. -2017. -Vol. 2017. -Art. ID 4803156. -9 p. -https://doi.org/10.1155/2017/4803156.
  • Hoarau G. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial crohn’s disease/G.Hoarau, P.K.Mukherjee, C.Gower-Rousseau et al.//MBio. -2016. -Vol. 7, N 5. -pii: e01250-16.
  • Hotamisligil G.S. Inflammation and metabolic disorders/G.S.Hotamisligil//Nature. -2006. -Vol. 444, N 7121. -P. 860-867.
  • Hotamisligil G.S. Inflammation, metaflammation and immunometabolic disorders/G.S.Hotamisligil//Nature. -2017. -Vol. 542, N 7640. -P. 177-185.
  • Huang W.K. Higher rate of colorectal cancer among patients with pyogenic liver abscess with Klebsiella pneumoniae than those without: an 11-year follow-up study/W.K.Huang, J.W.Chang, L.C.See et al.//Colorectal Dis. -2012. -Vol. 14, N 12. -P.e794-801.
  • Jung U.J. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease/U.J.Jung, M.S.Choi//Int. J. Mol. Sci. -2014. -Vol. 15, N 4. -P. 6184-5223.
  • Ksiaa F. Assessment and biological significance of JC polyomavirus in colorectal cancer in Tunisia/F.Ksiaa, A.Allous, S.Ziad et al.//JBUON. -2015. -Vol. 20, N 3. -P. 762-769.
  • Lai H.C. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study/H.C.Lai, C.C.Lin, K.S.Cheng et al.//Gastroenterology. -2014. -Vol. 146, N 1. -P. 129-137.
  • Langdon A. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation/A.Langdon, N.Crook, G. Dantas/Genome Med. -2016, -Vol. 8, N 1. -Art. 39.
  • Lange K. Effects of antibiotics on gut microbiota/K.Lange, M.Buerger. A.Stallmach, • T. Bruns//Dig. Dis. -2016. -Vol. 34, N 3. -P. 260-268.
  • Lee J.Y. Helicobacter pylori Infection with atrophic gastritis is an independent risk factor for advanced colonic neoplasm/J.Y.Lee, H.W.Park, J.Y.Choi et al.//Gut Liver. -2016. -Vol. 10, N 6. -P. 902-909.
  • van Leersum N.J. Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 1995-2010/N.J. van Leersum, M.L.Janssen-Heijnen, M.W.Wouters et al.//Int. J. Cancer. -2013. -Vol. 132, N 9. -P. 2157-2163.
  • Liguori G. Fungal dysbiosis in mucosa-associated microbiota of crohn’s disease patients/Liguori G., Lamas B., Richard M.L. et al.//J. Crohns. Colitis. -2016. -Vol. 10, N 3. -P. 296-305.
  • Liu F. Prevalence of human papillomavirus in Chinese patients with colorectal cancer/F.Liu, X.Mou, N.Zhao et al.//Colorectal Dis. -2011. -Vol. 13. -P. 865-871.
  • Lopes P.G. Novel real-time PCR assays using TaqMan minor groove binder probes for identification of fecal carriage of Streptococcus bovis/Streptococcus equinus complex from rectal swab specimens/P.G.Lopes, V.V.Cantarelli, G.Agnes et al.//J. Clin. Microbiol. -2014. -Vol. 52, N 3. -P. 974-976.
  • López-Abente G. Colorectal cancer mortality and industrial pollution in Spain/G.Löpez-Abente, J.Garcfa-Pérez, P.Fernândez-Navarro et al.//BMC Public Health. -2012. -Vol. 12. -Art. 589. -12 p.
  • Mao E. Clostridium septicum sepsis and colon carcinoma: report of 4 cases/E.Mao, A.Clements, E.Feller//Case Rep. Med. -2011. -Vol. 2011. -Art. ID 248453. -3 p. -https://www.hindawi.com/journals/crim/2011/248453/.
  • Marmol I. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer/I.Marmol, C.Sanchez-de-Diego, A.Pradilla Dieste//Int. J. Mol. Sci. -2017. -Vol. 18. N 1. -Art. 197.
  • Mou X. Prevalence of JC virus in Chinese patients with colorectal cancer/X.Mou, L.Chen, F.Liu et al.//PLoS One. -2012. -Vol. 7. -Art. e35900.
  • Nanjappa S. Clostridium septicum Gas Gangrene in Colon Cancer: Importance of Early Diagnosis/S.Nanjappa, S.Shah, S.Pabbathi//Case Rep. Infect. Dis. -2015. -Vol. 2015. -Art. ID 694247. -3 p. -https://www.hindawi.com/journals/criid/2015/694247/.
  • Nicholson J.K. Host-gut microbiota metabolic interactions/J.K.Nicholson, E.Holmes, J.Kinross et al.//Science. -2012. -Vol. 336, N 6086. -P. 1262-1267.
  • Nistal E. Factors determining colorectal cancer: The role of the intestinal microbiota/E.Nistal, N.Fernandez-Fernandez, S.Vivas, J.L.Olcoz//Front. Oncol. -2015. -Vol. 5. -Art. 220. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601259/.
  • Nosho K. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer/K.Nosho, Y.Sukawa, Adachi Y. et al.//World J. Gastroenterol. -2016. -Vol. 22, N 2. -P. 557-566.
  • Papastergiou V. Helicobacter pylori and colorectal neoplasia: Is there a causal link?/V.Papastergiou, S.Karatapanis, S.D.Georgopoulos//World J. Gastroenterol. -2016. -Vol. 22, N 2. -P. 649-658.
  • Pelizzer T. Colorectal cancer prevalence linked to human papillomavirus: a systematic review with meta-analysis/T.Pelizzer, C.P.Dias,J.Poeta et al.//Rev. Bras. Epidemiol. -2016. -Vol. 19, N 4. -http://dx.doi.o DOI: rg/10.1590/1980-5497201600040009
  • Pourhoseingholi M.A. Epidemiology and burden of colorectal cancer in Asia-Pacific region: what shall we do now?/M.A.Pourhoseingholi//Translational Gastrointestinal Cancer. -2014. -Vol. 3, N 4. -http://tgc.amegroups.com/article/view/4445/5581.
  • Purcell R.V. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia/R.V.Purcell, J.Pearson, A.Aitchison et al.//PLoS One. -2017. -Vol. 12, N 2. -Art. e0171602.
  • Sanmiguel C. Gut microbiome and obesity: A plausible explanation for obesity/C.Sanmiguel, A.Gupta, E.A.Mayer et al.//Curr. Obes. Rep. -2015. -Vol. 4, N 2. -P.250-261.
  • Schottenfeld D. The cancer burden attributable to biologic agents/D.Schottenfeld, J.Beebe-Dimmer//Ann Epidemiol. -2015. -Vol. 25, N 3. -P. 183-187.
  • Sears C.L. Microbes, microbiota, and colon cancer/C.L.Sears, W.S.Garrett//Cell Host Microbe. -2014. -Vol. 15, N 3. -P. 317-328.
  • Shawki A. Mechanisms of intestinal epithelial barrier dysfunction by adherent-invasive Escherichia coli/Shawki A., D.F.McCole//Cell. Mol. Gastroenterol. Hepatol. -2017. -Vol. 3, N 1. -P. 41-50.
  • Schlesinger S. Body weight gain and risk of colorectal cancer: a systematic review and meta-analysis of observational studies/S.Schlesinger, W.Lieb, M.Koch et al.//Obes. Rev. -2015. -Vol. 16, N 7. -P. 607-619.
  • Singh R.B. Globalization of dietary wild foods protect against cardiovascular disease and all cause mortalities? A scientific statement from the International College of Cardiology, Columbus Paradigm Institute and the International College of Nutrition/R.B.Singh, F.DeMeester, D.Pella et al.//Open Nutraceuticals J. -2009. -N 2. -P. 42-45.
  • Sobhani I. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?/I.Sobhani, A. Amiot, Yann Le Baleur et al.//Thera.p Adv. Gastroenterol. -2013. -Vol. 6, N 3. -P. 215-229.
  • Sonnenberg A. Helicobacter pylori is a risk factor for colonic neoplasms./A.Sonnenberg, R.M.Genta//Amer. J. Gastroenterol. -2013. -Vol. 108, N 2. -P. 208-215.
  • Zhou Y. Association of oncogenic bacteria with colorectal cancer in South China/Y.Zhou, H.He, H.Xu et al.//Oncotarget, -2016. -Vol. 7, N 49. -P. 80794-80802.
Еще
Статья